Some AD biomarkers, including Reelin, were detected in heavy amounts in ocular fluids, showing correlations with plasma levels, an interesting point for the developing of future tests to quantify ocular fluid biomarkers as diagnostic and prognostic markers of AD, especially for those at risk of ocular and cognitive disease [30,31,32]. The gene discussed is RELN; the disease is Alzheimer disease.